FMP
Wells Fargo Reiterates Overweight on NVIDIA After Groq Licensing Clarification
Wells Fargo reiterated its Overweight rating and $265 price target on NVIDIA (NASDAQ: NVDA), following clarification around the company’s relationship with privately held AI hardware firm Groq. The...
Lake Street Lifts Velo3D Target as Reshoring and Defense Tailwinds Strengthen Case
Lake Street Capital Markets raised its price target on Velo3D (NASDAQ: VELO) to $18 from $6 while maintaining a Buy rati...
Bernstein Reaffirms Outperform on Gilead as Medicaid Risk Appears Contained
Bernstein SocGen Group reiterated its Outperform rating and $135 price target on Gilead Sciences (NASDAQ: GILD), citing ...
Bernstein Cuts Lamb Weston Target as Profit Outlook Raises 2027 Concerns
Bernstein SocGen Group lowered its price target on Lamb Weston (NYSE: LW) to $46 from $65 while maintaining a Market Per...
Clear Street Raises Intuitive Machines Price Target Following Lanteris Acquisition
Clear Street raised its price target on Intuitive Machines (NASDAQ: LUNR) to $25 from $17 while maintaining a Buy rating...
MoffettNathanson Reiterates Buy on Datadog After Post-Peak Pullback
MoffettNathanson reiterated a Buy rating and $255 price target on Datadog (NASDAQ: DDOG), arguing that the stock’s recen...
BofA Maintains Buy Rating on NVIDIA After Groq Licensing News
BofA Securities reiterated its Buy rating and $275 price target on NVIDIA Corp. (NASDAQ: NVDA), following news that priv...
UBS Reaffirms Neutral View on Nike Despite Improving Brand Indicators
UBS reiterated a Neutral rating and a $62 price target on Nike Inc. (NYSE: NKE), citing improving brand momentum but a l...
Freedom Capital Initiates MDU Resources Coverage With Hold Rating
Freedom Capital Markets initiated coverage on MDU Resources Group Inc. (NYSE: MDU) with a Hold rating and a $20 price ta...
H.C. Wainwright Maintains Neutral Stance on Biohaven After BHV-7000 Setback
H.C. Wainwright reiterated a Neutral rating and $11 price target on Biohaven Pharmaceutical Holding Co. (NYSE: BHVN) fol...
Agios Pharma Shares Surge After FDA Approval of Mitapivat
Agios Pharmaceuticals Inc. (NASDAQ: AGIO) shares jumped 18% on Thursday after the company received U.S. Food and Drug Ad...
BMO Reiterates Market Perform on Halliburton, Sees Resilient North America Trends
BMO Capital reiterated a Market Perform rating and a $31 price target on Halliburton (NYSE: HAL), pointing to relative r...
Raymond James Downgrades KB Home Amid Strategic and Competitive Concerns
Raymond James downgraded KB Home (NYSE: KBH) to Market Perform from Outperform, citing disappointment with fourth-quarte...
Lake Street Raises Dave Inc Price Target as Credit Trends and Monetization Improve
Lake Street Capital Markets raised its price target on Dave Inc. (NASDAQ: DAVE) to $308 from $263 while reiterating a Bu...
B. Riley Cuts WhiteFiber Target While Highlighting Execution Progress at NC-1
B. Riley lowered its price target on WhiteFiber Inc. (NASDAQ: WYFI) to $40 from $44 while maintaining a Buy rating, foll...
Noble Capital Downgrades Comstock Mining as Capital Needs Remain Elevated
Noble Capital downgraded Comstock Mining Inc. (NYSE: LODE) to Market Perform from Outperform, citing ongoing near-term f...
Americold Realty Trust Partners with On the Run to Enter Convenience Store Distribution
Americold Realty Trust, listed on the NYSE under the symbol COLD, is a leader in temperature-controlled logistics. The c...
Recent Market Movers: A Detailed Analysis
In recent market analysis, several companies have experienced significant price movements, reflecting a range of underly...
Hamilton Insurance Group, Ltd. (NYSE: HG) Price Target and Analyst Ratings Update
Hamilton Insurance Group, Ltd. (NYSE: HG) is a prominent player in the insurance industry, offering a range of insurance...
Marvell Technology Inc. (NASDAQ:MRVL) Overview: Strategic Moves in the AI Semiconductor Industry
Marvell Technology Inc. (NASDAQ:MRVL) is a prominent player in the AI semiconductor industry, known for its innovative s...
